We discuss selected issues concerning the design of stroke treatment trials. Key issues include the type of stroke studied, the time interval from stroke onset to patient entry, and whether to include cardioembolic strokes and allow concomitant therapy.
No takes yet. Share an insight, caveat, or question.
Sterman et al. (1987) studied this question.